ArticleArthritis & rheumatology (Hoboken, N.J.)2022

Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune Diseases.

Samuel Bitoun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.